Medivation Inc news

   Watch this stock
Showing stories 1 - 10 of about 35   

Articles published

MDVN 91.43 -0.64 (-0.70%)
price chart
Medivation Emerges With New Prostate Cancer Drug
San Francisco-based Medivation doesn't quite have the brand name recognition of its rivals in the world of prostate cancer drug development, but that could be starting to change, as soon as this weekend.
From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story
Buried in the news of the past month, which was admittedly a busy one, was a press release headlined: “Geomagic Acquires Sensable 3D Design and Haptics Businesses.
Study: J&J's Zytiga Can Eliminate Some Prostate Tumors
Dr. Taplin and other researchers have started another study looking at Medivation Inc. MDVN -1.37 % 's experimental drug enzalutamide for use as a treatment before surgery.
J&J's Zytiga Helps Eliminate Early-Stage Prostate Cancer  Bloomberg
Ember CEO: Silicon Labs Acquisition for $72M Is “Right Thing for the Company”
It seems like it takes most tech companies about 10 years to run their course—if they survive the first few years, that is. Boston-based Ember is no exception.
Dendreon's Provenge Works Best for Patients With Low PSA, Scientists Say
Since then, the company has faced a series of new competitive threats, particularly from Johnson & Johnson's abiraterone (Zytiga) and Medivation's enzalutamide. Those drugs are starting out by aiming to treat the sickest of prostate cancer patients ...
Kyruus Takes Big Data Approach to Identify Qualified Physicians
Hospitals typically check patients in with one system, track their healthcare with another, and process insurance claims with yet another.
Buddy Platform Open for Business, Raises $1M for App Backend Service
Buddy Platform, a Kirkland, WA-based startup that sells back-end services for mobile apps, is now open for business and says it has raised $1 million from investors.
Why Facebook Is Killing Silicon Valley
I teach entrepreneurship to about 50 student teams a year from engineering schools at Stanford, Berkeley, and Columbia. For the National Science Foundation Innovation Corps this year I'll also teach roughly 150 teams led by professors who want to ...
With Orders Piling Up, Zulily Built a Shipping Arm—in 8 Weeks
When you build a fast-growing business, there are bound to be a few “oh shit” moments. Darrell Cavens, the CEO of moms-and-kids retailer Zulily, knows that feeling well.
Can Pocket (n�e Read It Later) Become the TiVo of the Web?
On the iPhone, the first page of the home screen—the one you see when you wake up the device—has room for only 20 apps, counting those in the dock.